Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb-salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, and telemedicine access services. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, patient communications and engagement support, and value-based care solutions to hospitals, health systems, physician practices, employers, and other customers. As of December 31, 2020, the company operated 65 hospitals; and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and other care sites and clinics. Tenet Healthcare Corporation was incorporated in 1975 and is headquartered in Dallas, Texas.
IPO Year:
Exchange: NYSE
Website: tenethealth.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/29/2025 | $195.00 | Equal Weight → Overweight | Wells Fargo |
| 4/15/2025 | $137.00 | Outperform → Neutral | Robert W. Baird |
| 3/26/2025 | $165.00 | Overweight | Morgan Stanley |
| 2/26/2025 | $175.00 | Buy | TD Cowen |
| 12/17/2024 | $175.00 | Overweight | Analyst |
| 12/16/2024 | $196.00 → $140.00 | Buy → Neutral | Goldman |
| 11/25/2024 | $205.00 → $150.00 | Overweight → Equal Weight | Wells Fargo |
| 11/22/2024 | $195.00 | Strong Buy → Outperform | Raymond James |
| 10/11/2024 | $200.00 | Overweight | KeyBanc Capital Markets |
| 5/30/2024 | $153.00 | Outperform | Robert W. Baird |
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
144 - TENET HEALTHCARE CORP (0000070318) (Subject)
10-Q - TENET HEALTHCARE CORP (0000070318) (Filer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
PX14A6G - TENET HEALTHCARE CORP (0000070318) (Subject)
10-K - TENET HEALTHCARE CORP (0000070318) (Filer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
10-Q - TENET HEALTHCARE CORP (0000070318) (Filer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
Tenet Healthcare Corporation (NYSE:THC) is scheduled to present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, beginning at 1:40 p.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals.
Net income available to common shareholders in first quarter 2025 was $406 million, or $4.27 per diluted share Adjusted diluted earnings per share1 increased 35.4% to $4.36 in first quarter 2025 compared to $3.22 in first quarter 2024 Consolidated Adjusted EBITDA1 in first quarter 2025 increased 13.6% to $1.163 billion compared to first quarter 2024; First quarter 2025 Adjusted EBITDA margin was 22.3% First quarter 2025 Ambulatory Care Adjusted EBITDA of $456 million increased 15.7% over first quarter 2024 FY 2025 Adjusted EBITDA Outlook is expected to be in the range of $3.975 billion to $4.175 billion Tenet Healthcare Corporation (Tenet) (NYSE:THC) today announced its results f
Tenet Healthcare Corporation (NYSE:THC) will release its first quarter 2025 results before the market opens on Tuesday, April 29, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We als
Tenet Healthcare Corporation (NYSE:THC) is scheduled to present virtually at the Barclays 27th Annual Global Healthcare Conference on Wednesday, March 12, 2024, beginning at 10:00 a.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers
Net income available to common shareholders in fourth quarter 2024 was $318 million, or $3.32 per diluted share Adjusted diluted earnings per share1 was $3.44 in fourth quarter 2024 Consolidated Adjusted EBITDA1 in fourth quarter 2024 was $1.048 billion, which represents an Adjusted EBITDA margin of 20.7% Fourth quarter 2024 Ambulatory Care Adjusted EBITDA of $530 million increased 14.2% over fourth quarter 2023 FY 2025 Adjusted EBITDA Outlook is expected to be in the range of $3.975 billion to $4.175 billion Tenet Healthcare Corporation (Tenet) (NYSE:THC) today announced its results for the quarter ended December 31, 2024. "2024 was an outstanding year for Tenet character
Tenet Healthcare Corporation (NYSE:THC) will release its fourth quarter 2024 results before the market opens on Wednesday, February 12, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospital
MOUNTAIN VIEW, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Commure, a leader in healthcare technology innovation, announced today that Tenet Healthcare Corporation (NYSE:THC), one of the nation's largest healthcare providers, has selected Commure Scribe, an ambient AI platform, to be launched across its employed physician network, Tenet Physician Resources. This relationship solidifies Commure as the most comprehensive platform solution provider for AI within health systems. Its reach includes tens of thousands of physicians across sixty of the largest IDNs (Integrated Delivery Networks) in the country. Commure's ambient AI platform spans the entire patient journey and clinician workflow,
Net income available to common shareholders in third quarter 2024 was $472 million, or $4.89 per diluted share, including an after-tax gain of $209 million, or $2.16 per diluted share, primarily associated with previously announced hospital divestitures Adjusted diluted earnings per share1 was $2.93 in third quarter 2024 Consolidated Adjusted EBITDA1 in third quarter 2024 of $978 million increased 14.5% over third quarter 2023 Third quarter 2024 Ambulatory Care Adjusted EBITDA of $439 million increased 18.6% over third quarter 2023 FY 2024 Adjusted EBITDA Outlook now expected to be in the range of $3.9 billion to $4.0 billion, a $50 million increase Tenet Healthcare Corporati
Tenet Healthcare Corporation (NYSE:THC) is scheduled to present at the UBS Global Healthcare Conference on Tuesday, November 12, 2024, beginning at 12:30 p.m. Eastern time. A live webcast and audio archive of the event may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will be available for 30 days. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We al
Tenet Healthcare Corporation (NYSE:THC) will release its third quarter 2024 results before the market opens on Tuesday, October 29, 2024, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We a
Wells Fargo upgraded Tenet Healthcare from Equal Weight to Overweight and set a new price target of $195.00
Robert W. Baird downgraded Tenet Healthcare from Outperform to Neutral and set a new price target of $137.00
Morgan Stanley initiated coverage of Tenet Healthcare with a rating of Overweight and set a new price target of $165.00
TD Cowen initiated coverage of Tenet Healthcare with a rating of Buy and set a new price target of $175.00
Analyst resumed coverage of Tenet Healthcare with a rating of Overweight and set a new price target of $175.00
Goldman downgraded Tenet Healthcare from Buy to Neutral and set a new price target of $140.00 from $196.00 previously
Wells Fargo downgraded Tenet Healthcare from Overweight to Equal Weight and set a new price target of $150.00 from $205.00 previously
Raymond James downgraded Tenet Healthcare from Strong Buy to Outperform and set a new price target of $195.00
KeyBanc Capital Markets initiated coverage of Tenet Healthcare with a rating of Overweight and set a new price target of $200.00
Robert W. Baird initiated coverage of Tenet Healthcare with a rating of Outperform and set a new price target of $153.00
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
Tenet Healthcare Corporation (NYSE:THC) will release its first quarter 2025 results before the market opens on Tuesday, April 29, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We als
Tenet Healthcare Corporation (NYSE:THC) will release its fourth quarter 2024 results before the market opens on Wednesday, February 12, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospital
Tenet Healthcare Corporation (NYSE:THC) will release its third quarter 2024 results before the market opens on Tuesday, October 29, 2024, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We a
Tenet Healthcare Corporation (NYSE:THC) will release its second quarter 2024 results on Wednesday, July 24, 2024, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and su
Tenet Healthcare Corporation (NYSE:THC) will release its first quarter 2024 results on Tuesday, April 30, 2024, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more
Tenet completes sale of three South Carolina hospitals and announces the sale of four Orange County and Los Angeles County hospitals and related operations. Tenet Healthcare Corporation (NYSE:THC) today announced that it has completed the sale of three of its hospitals and related operations in South Carolina to Novant Health for approximately $2.4 billion. Tenet also announced it has entered into a definitive agreement with UCI Health for the sale of four Tenet hospitals and related operations in Orange County and Los Angeles County, California for approximately $975 million in cash. In addition, Tenet announced that it expects to exceed the high end of its latest FY23 Adjusted EBITDA Ou
Tenet Healthcare Corporation (NYSE:THC) will release its fourth quarter 2023 results on Thursday, February 8, 2024, no later than 6:00 a.m. Central Time (CT), to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in m
Tenet Healthcare Corporation (NYSE:THC) will release its third quarter 2023 results after the market closes on Monday, October 30, 2023, to be followed by a conference call at 4:00 p.m. CT (5:00 p.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 475 ambulatory
Tenet Healthcare Corporation (NYSE:THC) will release its second quarter 2023 results after the market closes on Monday, July 31, 2023, to be followed by a conference call at 4:00 p.m. CT (5:00 p.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 465 ambulatory s
Tenet Healthcare Corporation (NYSE:THC) will release its first quarter 2023 results before the market opens on Tuesday, April 25, 2023, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates or has ownership interests in more than 465 ambulatory su
Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Vineeta Agarwala, M.D., PhD, to its Board of Directors, effective immediately. Dr. Agarwala will serve as a member of the Quality, Compliance, and Ethics Committee, as well as the Human Resources Committee, increasing the size of the Board to 13 directors. "We are pleased to welcome Dr. Vineeta Agarwala to the Tenet Board," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "Vineeta is a leader in healthcare in her own right. Her expertise in innovative technologies, including applications of artificial intelligence will enhance our governance in a rapidly evolving healthcare marketplace." Dr
Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Senator Roy Blunt to the Tenet Board of Directors, effective immediately. Senator Blunt will serve as a member of the Audit Committee, Nominating and Corporate Governance Committee, and Environmental, Social, and Governance Committee. This appointment expands the Board to 12 directors, 11 of whom are independent members. "We are pleased to welcome Senator Roy Blunt as a new board member," said Saum Sutaria, M.D., Chief Executive Officer of Tenet. "With more than 25 years of legislative experience, Roy's expertise in public policy and addressing cross-cutting issues will be invaluable to helping Tenet make a lasting
Tenet Healthcare Corporation (NYSE:THC) today announced that its Board of Directors has elected Chief Executive Officer, Saum Sutaria, M.D., to assume the additional position of Chairman, effective immediately. Sutaria succeeds Senator J. Robert Kerrey, who will transition to Lead Director of the Board, a role he previously held from 2017- 2022. Sutaria has served as Tenet Healthcare's CEO since September 2021 and a member of the Board of Directors since 2020. Previously, he served as the Company's Chief Operating Officer. "The appointment of Saum to Chairman is a testament to his steadfast leadership and commitment to Tenet Healthcare," said Senator J. Robert Kerrey, Lead Director. "Th
Tenet Healthcare Corporation (NYSE:THC) announced the appointment of Sun Park as Executive Vice President & Chief Financial Officer of the Company, effective January 1, 2024, as part of the Company's planned Chief Financial Officer transition. Mr. Park will serve as an Executive Vice President of the Company from July 11, 2023 through December 31, 2023. As previously announced, Dan Cancelmi, Executive Vice President & Chief Financial Officer, will retire at the end of 2023. Mr. Park will succeed Mr. Cancelmi in that capacity and report to Saum Sutaria, M.D., Chief Executive Officer of Tenet. Mr. Park is an experienced healthcare executive with a track record of driving results. He has str
Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Stephen H. Rusckowski to the Tenet Board of Directors, effective immediately. Rusckowski will serve as a member of the human resources committee and quality, compliance, and ethics committee. This appointment expands the Board to 11 directors, 10 of whom are independent members. "We are pleased to announce Steve Rusckowski as a new board member for Tenet," said Saum Sutaria, M.D., Chief Executive Officer of Tenet. "Steve has extensive experience with multinational healthcare corporations that complements our Board. He supports Tenet's commitment to expanding high-quality, specialty care access while protecting the
Board Appointments Support the Company's Previously Announced Board Transition Plan Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC ("Cruiser") and Harbour Point Capital Management LP ("Harbour Point" ), which collectively own approximately 4.7% of the outstanding shares of Enhabit's common stock, pursuant to which Enhabit has appointed Stuart McGuigan and Barry Schochet to its board of directors, effective immediately. With these appointments the Company's board will expand temporarily to 13 directors. As Enhabit previously disclosed in May 2022 ahead of the complet
Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Will McDowell as Vice President, Investor Relations. McDowell will join Tenet on March 31, 2022, after more than two decades serving in leadership roles at Cigna Corporation. McDowell currently serves as Cigna's Vice President, Strategy and Corporate Development, where he is responsible for expanding relationships with private market buyers and implementing the company's mergers and acquisitions (M&A) plan. Previously, he worked for nearly a decade in Investor Relations (IR) at Cigna, including leading the function for six years as Vice President. "Will is a seasoned, relationship-driven executive who brings a broa
Tenet Healthcare Corporation (NYSE:THC) announced today that Regina Nethery, Vice President of Investor Relations, has chosen to retire from her position, effective at the end of 2021. "We are extremely grateful to Regina for her thoughtful, strategic counsel and tremendous contributions to the organization throughout her tenure," said Dan Cancelmi, Executive Vice President and Chief Financial Officer. "Regina's recent recognition as one of the best Investor Relations professionals in Institutional Investor's survey of Wall Street analysts is a testament to her exceptional contributions to the Company. We will miss Regina and wish her the best on her retirement." "I am pleased to have had
Net income from continuing operations available to common shareholders in Q3'21 of $448 million versus a net loss from continuing operations of $197 million in Q3'20 Consolidated Adjusted EBITDA in Q3'21 of $855 million ($851 million excluding $4 million of COVID stimulus grant income) versus $551 million in Q3'20 ($621 million excluding $(70) million of grant income) Diluted earnings per share from continuing operations available to common shareholders in Q3'21 of $4.12 compared to a loss per share of $1.87 in Q3'20; Adjusted diluted earnings per share from continuing operations of $1.99 in Q3'21 compared to $0.64 in Q3'20 Same-hospital adjusted admissions increased 4.4% versus Q
Saum Sutaria appointed Chief Executive Officer; Ron Rittenmeyer remains Executive Chairman of Tenet Tenet Healthcare Corporation (NYSE:THC) today announced the next step in its long-term leadership succession plan. Ron Rittenmeyer, who has served as CEO and Executive Chairman for nearly four years, will continue as Executive Chairman of the Company and the Board through 2022. Saum Sutaria, M.D., President and Chief Operating Officer of Tenet, will become Chief Executive Officer, effective September 1, 2021. He will continue to report to Rittenmeyer. "When I joined Tenet as Executive Chairman and CEO almost four years ago, I had two major objectives," said Rittenmeyer. "First, was the tran